Back to News
Market Impact: 0.3
Moderna Stock Is Soaring: What's Going On?
Source: benzinga.com
Healthcare & BiotechProduct Launches
Moderna shares surged Monday after three abstracts on its personalized cancer vaccine, intismeran autogene, were accepted for presentation at the European Society for Medical Oncology Congress. The accepted abstracts provide a near-term scientific catalyst and could support investor confidence in Moderna's oncology pipeline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.42
Ticker Sentiment
MRNA0.62
More News
- Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- While biotech bets swing on trial data, this dividend payer gained 72% since 2024
- RIP the Cybertruck: Elon Musk says Tesla will wind down production of its most polarizing EV
- Tesla will stop making the Cybertruck in 2027
- Globus Medical stock holds at Neutral as BTIG cites revenue miss
- Canaccord reiterates Natera stock rating on strong Q3 results